Scynexis (SCYX) Non Operating Income (2013 - 2026)
Scynexis (SCYX) reported Non Operating Income of -$4.4 million for Q1 2026, down 235.45% on a YoY basis from $3.2 million in Q1 2025, and down 351.01% quarter-over-quarter from $1.7 million in Q4 2025.
Scynexis (SCYX) Non Operating Income (2013 - 2026) Analysis & Trends
Scynexis has reported Non Operating Income for 14 years, with the latest figure at -$4.4 million in Q1 2026.
- For the quarter ending Q1 2026, Non Operating Income fell 235.45% year-over-year to -$4.4 million; the trailing twelve-month figure through Mar 2026 stood at -$133000.0 (down 101.52% YoY), and the FY2025 full-year result was $7.5 million, down 53.29% from the prior year.
- Non Operating Income for Q1 2026 stood at -$4.4 million, down from $1.7 million in the prior quarter.
- The five-year high for Non Operating Income was $10.4 million in Q1 2024, with the low at -$23.2 million in Q1 2023.
- Historically, Non Operating Income has averaged $1.9 million across 5 years, with a median of $3.6 million in 2023.
- Annual changes were most pronounced in 2022 — Non Operating Income jumped 583.7% — and 2023, when it slumped 341.93%.
- Scynexis' Non Operating Income stood at $8.1 million in 2022, then slumped by 55.08% to $3.6 million in 2023, then advanced by 0.72% to $3.6 million in 2024, then plunged by 52.32% to $1.7 million in 2025, then tumbled by 351.01% to -$4.4 million in 2026.
- The last three Non Operating Income figures came in at -$4.4 million (Q1 2026), $1.7 million (Q4 2025), and -$186000.0 (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non Op. Inc. (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn | -216.00 Mn |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn | 20.00 Mn |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn | -7.50 Mn |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn | -504,111.66 |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn | 53.40 Mn |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn | - |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn | -13.65 Mn |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn | -23.23 Mn |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn | 5.71 Mn |
| 10 | Scynexis | 225.23 Mn | 165.97 Mn | - | -4.36 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -4.36 Mn |
| Dec 31, 2025 | 1.74 Mn |
| Sep 30, 2025 | -186,000.00 |
| Jun 30, 2025 | 2.68 Mn |
| Mar 31, 2025 | 3.22 Mn |
| Dec 31, 2024 | 3.64 Mn |
| Sep 30, 2024 | 7.12 Mn |
| Jun 30, 2024 | -5.22 Mn |
| Mar 31, 2024 | 10.45 Mn |
| Dec 31, 2023 | 3.62 Mn |
| Sep 30, 2023 | 8.34 Mn |
| Jun 30, 2023 | 5.75 Mn |
| Mar 31, 2023 | -23.19 Mn |
| Dec 31, 2022 | 8.05 Mn |
| Sep 30, 2022 | -7.78 Mn |
| Jun 30, 2022 | 8.39 Mn |
| Mar 31, 2022 | 9.59 Mn |
| Dec 31, 2021 | -30.73 Mn |
| Sep 30, 2021 | 18.79 Mn |
| Jun 30, 2021 | 15.03 Mn |